Fecal Incontinence Therapeutics- Pipeline Analysis 2018
Fecal incontinence, also known as accidental bowel leakage, refers to the inability of a person to control bowel movement including stools and mucus. Urge incontinence is a common form of fecal incontinence that occur due to pelvic muscle injury or nerve damage.Download the sample report at: https://www.pharmaproff.com/request-sample/1026
Passive incontinence is another type of fecal incontinence in which passing of stools is unknown to the patient. Some of the risk factor associated with fecal incontinence are gastrointestinal disorders, such as diarrhoea, constipation, and hemorrhoids.
Get the detailed analysis at: https://www.pharmaproff.com/report/fecal-incontinence-therapeutics-pipeline-analysis
RDD Pharma Ltd. is in the process of developing RDD-0315 as an alpha-adrenergic receptor agonist for the treatment of fecal incontinence. The company has recently completed a successful Phase 2a study of RDD 0315 in fecal incontinence, which reached the primary endpoint (lowered frequency of incontinence events).
Make enquiry before purchase at: https://www.pharmaproff.com/enquiry/1026
• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.
About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.
Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fecal Incontinence Therapeutics- Pipeline Analysis 2018 here
News-ID: 1750399 • Views: …
More Releases for RDD
Global Anal Fissure Treatment Market Size Share, Size, Growth Opportunities: Ind …
The Anal Fissure Treatment report published by Data Bridge Market research is the portrayal of information and investigation of the market. It gives nitty gritty examination of the current market situation and a market estimate till 2027. The information remembered for this Anal Fissure Treatment report gives point by point data of the geographic scene, serious situations and up and coming open doors in the Industry. The incorporation of the…
Global Anal Fissure Treatment Market 2020: Competitive Landscape, Key Players, F …
Global anal fissure treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.
The wide ranging anal fissure treatment market analysis report precisely collects the information about…
Global Anal Fissure Treatment Market 2020:Competitive Analysis By Teva Pharmaceu …
Global anal fissure treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.
Data Bridge Market Research recently published a market study on the anal fissure treatment…
Global Pruritus Drug Market 2020:Quantitative Analysis By Novus Therapeutics, In …
Global pruritus drug market is growing at a substantial CAGR in the forecast period of 2019-2026. Increasing research and development expenses and high demand of novel therapies are some factors fueling the market growth.
Pruritus drug market report comprises of historic data along with future forecast and detailed market analysis on a global, local and regional level for Pharmaceutical industry. The pruritus drug report helps out in mapping brand awareness,…
Anal Fissure Therapeutics Market Size will Escalate Rapidly in the Near Future 2 …
Anal fissure is a linear tear in the mucosal lining of the distal anal canal below the dentate line. The common symptoms of an anal fissure include severe pain during and after a bowel movement lasting for several minutes to few hours. These fissures occur mainly because due to trauma to the inner lining of the anus, most of the times a hard, dry bowel movement is typically responsible but…
Anal Fissure Therapeutics Market Current Trends and Future Aspect Analysis 2017 …
Anal fissure is a linear tear in the mucosal lining of the distal anal canal below the dentate line. The common symptoms of an anal fissure include severe pain during and after a bowel movement lasting for several minutes to few hours. These fissures occur mainly because due to trauma to the inner lining of the anus, most of the times a hard, dry bowel movement is typically responsible but…